Eventide Healthcare & Life Sciences Fund CLDX Holdings History
Eventide Healthcare & Life Sciences Fund's Celldex Therapeutics Inc Holding Summary
As of 2025-03-31, MUTUAL FUND SERIES TRUST held 1.36 Mil shares of Celldex Therapeutics Inc(CLDX), totaling $24.61 Mil. This investment constitutes 2.46% of their stock portfolio, and MUTUAL FUND SERIES TRUST now holds 2.04% of the outstanding Celldex Therapeutics Inc(CLDX) stock.
The initial trade took place in 2020Q2. And since then Eventide Healthcare & Life Sciences Fund has made 9 purchases of CLDX, at an average price of $28.56, for a total of 21.77 Mil shares. In addition, there have been 5 sales at an average price of $30.96 for 20.68 Mil shares. Based on historical transaction data and CLDX's current price of $22.41, Eventide Healthcare & Life Sciences Fund's estimated gain on his CLDX holdings is $42.89 Mil, reflecting a 6.90% gain to date.
Eventide Healthcare & Life Sciences Fund CLDX ($22.41) Holding Chart
Eventide Healthcare & Life Sciences Fund CLDX ($22.41) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
